Lingyan Chen Selected Research

Lingyan Chen Research Topics

Disease

14	Neoplasms (Cancer) 02/2024 - 10/2020
4	Inflammation (Inflammations) 01/2022 - 06/2017
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 12/2015
3	Breast Neoplasms (Breast Cancer) 01/2024 - 10/2022
3	Intrahepatic Cholestasis of Pregnancy 11/2023 - 01/2023
3	Non-alcoholic Fatty Liver Disease 05/2023 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 11/2022 - 01/2022
2	Pruritus (Itching) 11/2023 - 01/2023
2	Diabetes Mellitus 11/2023 - 01/2017
2	Osteoporosis 01/2023 - 01/2023
2	Stroke (Strokes) 11/2022 - 10/2022
2	Vascular Diseases (Vascular Disease) 04/2022 - 01/2022
2	Insulin Resistance 01/2021 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 12/2015
1	Vomiting 04/2024
1	Ulcerative Colitis 01/2024
1	Crohn Disease (Crohn's Disease) 01/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024
1	Dysbiosis 01/2024
1	Sleep Wake Disorders 01/2024
1	Obesity 11/2023
1	Liver Diseases (Liver Disease) 11/2023
1	Albuminuria 11/2023
1	Prediabetic State (Prediabetes) 11/2023
1	Hyperglycemia 11/2023
1	Alcoholic Fatty Liver 05/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2023
1	Bone Resorption 01/2023
1	Sarcopenia 01/2023
1	Genetic Risk Score 11/2022
1	Atrial Fibrillation 10/2022
1	Adenocarcinoma 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Venous Thromboembolism 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2017
4	LipidsIBA 05/2023 - 06/2017
4	Triglycerides (Triacylglycerol)IBA 04/2023 - 01/2017
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2017
2	CalciumIBA 01/2024 - 01/2023
2	Blood Proteins (Serum Proteins)IBA 11/2023 - 10/2022
2	ProteomeIBA 11/2023 - 10/2022
2	Bile Acids and Salts (Bile Acids)IBA 11/2023 - 01/2023
2	CreatinineIBA 11/2023 - 11/2022
2	LigandsIBA 05/2023 - 10/2022
2	oxidized low density lipoproteinIBA 04/2023 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2023 - 01/2017
2	Ciclopirox (Loprox)FDA LinkGeneric 11/2022 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 11/2022 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 10/2022 - 07/2022
2	Endothelial Protein C ReceptorIBA 04/2022 - 01/2022
2	OsteocalcinIBA 01/2021 - 01/2021
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2017 - 02/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 02/2016
2	Cytochrome P-450 CYP2C19IBA 01/2017 - 02/2016
1	CollagenIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Virulence Factors (Pathogenicity Factors)IBA 01/2024
1	16S Ribosomal RNAIBA 01/2024
1	AlbuminsIBA 11/2023
1	Islet Amyloid PolypeptideIBA 05/2023
1	Small Interfering RNA (siRNA)IBA 05/2023
1	amidoximeIBA 05/2023
1	PPAR alphaIBA 05/2023
1	AcetylgalactosamineIBA 05/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2023
1	Glycoproteins (Glycoprotein)IBA 04/2023
1	Valine (L-Valine)FDA Link 04/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 02/2023
1	Liposomes (Liposome)IBA 02/2023
1	SphingomyelinsIBA 02/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2023
1	Membrane LipidsIBA 02/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 11/2022
1	Lipoprotein(a)IBA 11/2022
1	angiotensin I (1-7)IBA 10/2022
1	Angiotensin-Converting Enzyme 2IBA 10/2022
1	Immunologic Factors (Immunomodulators)IBA 10/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2022
1	Lapatinib (GW572016)FDA Link 10/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	CurcuminIBA 07/2022
1	Protein CIBA 01/2022
1	tanshinoneIBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021

Therapy/Procedure

6	Therapeutics 01/2024 - 02/2016
3	Immunotherapy 01/2024 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2024 - 10/2022
2	Polypharmacy 01/2019 - 01/2017
1	Resuscitation 04/2024
1	Radiotherapy 03/2023